Brian Lappas, MD, MPH
Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,488 | 203 | 95.9% |
| Education | $191.91 | 3 | 4.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $2,023 | 78 | $0 (2024) |
| Janssen Biotech, Inc. | $609.23 | 25 | $0 (2024) |
| PFIZER INC. | $233.56 | 14 | $0 (2024) |
| QOL Medical, LLC | $199.26 | 11 | $0 (2024) |
| Lilly USA, LLC | $194.15 | 9 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $185.45 | 10 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $152.10 | 8 | $0 (2024) |
| GENZYME CORPORATION | $150.34 | 7 | $0 (2024) |
| Ferring Pharmaceuticals Inc. | $144.60 | 8 | $0 (2024) |
| Celgene Corporation | $129.61 | 6 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,405 | 70 | ABBVIE INC. ($405.22) |
| 2023 | $1,419 | 65 | ABBVIE INC. ($695.42) |
| 2022 | $763.03 | 34 | ABBVIE INC. ($445.97) |
| 2021 | $21.27 | 1 | Ferring Pharmaceuticals Inc. ($21.27) |
| 2020 | $180.36 | 2 | AbbVie Inc. ($100.41) |
| 2019 | $763.95 | 26 | AbbVie, Inc. ($376.14) |
| 2018 | $126.84 | 8 | Janssen Biotech, Inc. ($126.84) |
All Payment Transactions
206 individual payment records from CMS Open Payments — Page 1 of 9
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/27/2024 | QOL Medical, LLC | SUCRAID (Drug) | Food and Beverage | Cash or cash equivalent | $15.07 | General |
| Category: THERAPY FOR CSID | ||||||
| 12/19/2024 | Braintree Laboratories, Inc. | SUTAB (Drug), SUFLAVE | Food and Beverage | In-kind items and services | $13.35 | General |
| Category: GI COLON PREP | ||||||
| 12/11/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $14.90 | General |
| Category: Gastroenterology | ||||||
| 12/10/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $23.82 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/02/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $20.95 | General |
| Category: IMMUNOLOGY | ||||||
| 11/26/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $19.29 | General |
| Category: IMMUNOLOGY | ||||||
| 11/25/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $15.38 | General |
| Category: IMMUNOLOGY | ||||||
| 11/18/2024 | Lilly USA, LLC | OMVOH (Drug) | Food and Beverage | In-kind items and services | $19.95 | General |
| Category: Immunology | ||||||
| 11/13/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $16.41 | General |
| Category: IMMUNOLOGY | ||||||
| 11/12/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $13.07 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/05/2024 | Celltrion USA Inc. | VEGZELMA (Biological) | Food and Beverage | In-kind items and services | $21.11 | General |
| Category: ONCOLOGY | ||||||
| 11/04/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $16.56 | General |
| Category: LIVER DISEASE | ||||||
| 10/28/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $17.99 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 10/24/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $13.97 | General |
| Category: LIVER DISEASE | ||||||
| 10/22/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $20.33 | General |
| 10/21/2024 | Lilly USA, LLC | OMVOH (Drug) | Food and Beverage | In-kind items and services | $23.41 | General |
| Category: Immunology | ||||||
| 10/17/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $17.31 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 10/16/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $18.66 | General |
| Category: Gastroenterology | ||||||
| 10/14/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $31.65 | General |
| Category: Immunology | ||||||
| 10/09/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | TRULANCE (Drug) | Food and Beverage | In-kind items and services | $15.90 | General |
| Category: Gastroenterology | ||||||
| 10/07/2024 | Lilly USA, LLC | OMVOH (Drug) | Food and Beverage | In-kind items and services | $29.71 | General |
| Category: Immunology | ||||||
| 10/03/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $13.71 | General |
| Category: IMMUNOLOGY | ||||||
| 09/30/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $26.50 | General |
| Category: Immunology | ||||||
| 09/27/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $28.64 | General |
| Category: IMMUNOLOGY | ||||||
| 09/26/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $20.11 | General |
| Category: Gastroenterology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 383 | 583 | $188,004 | $45,097 |
| 2022 | 9 | 420 | 622 | $195,055 | $47,437 |
| 2021 | 6 | 160 | 248 | $79,547 | $21,295 |
All Medicare Procedures & Services
23 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Office | 2023 | 93 | 276 | $49,680 | $13,725 | 27.6% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 78 | 78 | $56,792 | $13,649 | 24.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 53 | 53 | $14,550 | $5,460 | 37.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 47 | 55 | $11,000 | $4,688 | 42.6% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 36 | 37 | $25,041 | $2,454 | 9.8% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 38 | 44 | $24,516 | $2,389 | 9.7% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 18 | 18 | $3,236 | $1,425 | 44.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 20 | 22 | $3,190 | $1,307 | 41.0% |
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Office | 2022 | 94 | 274 | $49,320 | $14,114 | 28.6% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 66 | 66 | $48,055 | $10,764 | 22.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 73 | 73 | $20,040 | $7,779 | 38.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 55 | 72 | $14,150 | $6,218 | 43.9% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 51 | 52 | $35,193 | $3,271 | 9.3% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 35 | 37 | $20,616 | $2,313 | 11.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 23 | 25 | $3,425 | $1,276 | 37.3% |
| 46600 | Diagnostic exam of anus using an endoscope | Office | 2022 | 12 | 12 | $2,280 | $1,014 | 44.5% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 11 | 11 | $1,977 | $687.16 | 34.8% |
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Office | 2021 | 36 | 122 | $21,960 | $6,439 | 29.3% |
| 45385 | Removal of polyps or growths in large bowel using an endoscope (colonoscopy) using a mechanical snare | Facility | 2021 | 30 | 30 | $21,843 | $5,821 | 26.6% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 41 | 41 | $11,255 | $5,065 | 45.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 19 | 21 | $3,990 | $2,095 | 52.5% |
| 43239 | Biopsy of the esophagus, stomach, and/or upper small bowel using an endoscope | Facility | 2021 | 21 | 21 | $11,701 | $1,280 | 10.9% |
| 45380 | Biopsy of the large bowel using an endoscope (colonoscopy) | Facility | 2021 | 13 | 13 | $8,798 | $594.46 | 6.8% |
About Brian Lappas, MD, MPH
Brian Lappas, MD, MPH is a Student in an Organized Health Care Education/Training Program healthcare provider based in Chapel Hill, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/16/2015. The National Provider Identifier (NPI) number assigned to this provider is 1275920381.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Brian Lappas, MD, MPH has received a total of $4,680 in payments from pharmaceutical and medical device companies, with $1,405 received in 2024. These payments were reported across 206 transactions from 23 companies. The most common payment nature is "Food and Beverage" ($4,488).
As a Medicare-enrolled provider, Lappas has provided services to 963 Medicare beneficiaries, totaling 1,453 services with total Medicare billing of $113,829. Data is available for 3 years (2021–2023), covering 23 distinct procedure/service records.
Practice Information
- Specialty Student in an Organized Health Care Education/Training Program
- Other Specialties Gastroenterology
- Location Chapel Hill, NC
- Active Since 04/16/2015
- Last Updated 04/13/2021
- Taxonomy Code 390200000X
- Entity Type Individual
- NPI Number 1275920381
Products in Payments
- RINVOQ (Biological) $535.94
- CREON (Drug) $418.56
- STELARA (Biological) $391.09
- SKYRIZI (Biological) $356.84
- DUPIXENT (Biological) $276.69
- XELJANZ (Drug) $233.56
- OMVOH (Drug) $161.34
- XIFAXAN (Drug) $154.38
- ZEPOSIA (Drug) $129.61
- TREMFYA (Drug) $127.19
- Creon (Drug) $118.32
- Humira (Biological) $108.31
- ENTYVIO (Biological) $106.84
- CIMZIA (Drug) $106.64
- Sucraid (Drug) $100.19
- SUCRAID (Drug) $99.07
- LINZESS (Drug) $94.97
- REMICADE (Biological) $90.95
- Doptelet (Drug) $84.13
- DIFICID (Drug) $61.51
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Student in an Organized Health Care Education/Training Program Doctors in Chapel Hill
Dr. Joshua Zeidner, M.d, M.D
Student in an Organized Health Care Education/Training Program — Payments: $212,063
Brandi Reeves, Md, MD
Student in an Organized Health Care Education/Training Program — Payments: $155,412
Dr. Edward Barnes, Md, MD
Student in an Organized Health Care Education/Training Program — Payments: $143,116
Dr. Yasmina Abajas, Md, MD
Student in an Organized Health Care Education/Training Program — Payments: $105,055
Jason Franasiak, Md, MD
Student in an Organized Health Care Education/Training Program — Payments: $61,232
Klara Klein, Md/Phd, MD/PHD
Student in an Organized Health Care Education/Training Program — Payments: $49,555